Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention-Reference-Cited by-同舟云学术

Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention

Published:2012-04-23 Issue:5 Volume:39 Page:406-411
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Meng Shu¹,Wang Lian-Sheng²,Huang Zhou-Qing³,Zhou Qing¹,Sun Ying-Gang¹,Cao Jia-Tian⁴,Li Yi-Gang¹,Wang Chang-Qian⁴

Affiliation:

1. Department of Cardiology; Xinhua Hospital Affiliated to Shanghai Jiaotong University; School of Medicine

2. Departments of Laboratory Medicine

3. Department of Cardiology; The First Affiliated Hospital; Wenzhou Medical College; Wenzhou; China

4. Departments of Cardiology; Shanghai Ninth People's Hospital Affiliated to Shanghai Jiaotong University; School of Medicine; Shanghai

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1681.2012.05670.x/fullpdf

Reference46 articles.

1. Atherothrombosis and high-risk plaque: part I. Evolving concepts;Fuster;J. Am. Coll. Cardiol.,2005

2. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms;Schwartz;J. Am. Coll. Cardiol.,1992

3. The coronary artery response to implantation of a balloon-expandable flexible stent in the aspirin- and non-aspirin-treated swine model;Rodgers;Am. Heart J.,1991

4. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy;Patti;J. Am. Coll. Cardiol.,2006

5. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation;Kereiakes;Circulation,2003

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease;Current Reviews in Clinical and Experimental Pharmacology;2024-11

2. Targeting neutrophils extracellular traps, a promising anti-thrombotic therapy for natural products from traditional Chinese herbal medicine;Biomedicine & Pharmacotherapy;2024-10

3. Hypertriglyceridemia Therapy: Past, Present and Future Perspectives;International Journal of Molecular Sciences;2024-09-08

4. Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments;Cancer Letters;2024-08

5. Berberis vulgaris L. Root Extract as a Multi-Target Chemopreventive Agent against Colon Cancer Causing Apoptosis in Human Colon Adenocarcinoma Cell Lines;International Journal of Molecular Sciences;2024-04-27